AFP — AFT Pharmaceuticals Balance Sheet
0.000.00%
- AU$305.44m
- AU$321.62m
- NZ$208.02m
- 88
- 36
- 46
- 61
Annual balance sheet for AFT Pharmaceuticals, fiscal year end - March 31st, NZD millions except per share, conversion factor applied.
| 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3.21 | 7.94 | 4.75 | 12 | 11.1 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 29.2 | 29.9 | 39.6 | 41 | 43.2 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 67.9 | 77.5 | 94.6 | 106 | 108 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.79 | 3.36 | 3.37 | 3.82 | 3.25 | 
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 105 | 127 | 148 | 165 | 170 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 32.1 | 29.1 | 39.8 | 46.1 | 43.3 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 68.5 | 65 | 74.8 | 77.5 | 72.2 | 
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 36.6 | 62.3 | 73.3 | 87.8 | 97.6 | 
| Total Liabilities & Shareholders' Equity | 105 | 127 | 148 | 165 | 170 | 
| Total Common Shares Outstanding |